Individuals with chronic obstructive pulmonary disease (COPD) experience improved breathing symptoms and dyspnea with use of automated oxygen administration. Automated oxygen administration (AOA) was ...

Please provide your email address to receive an email when new articles are posted on . Across several subgroups, more patients receiving ensifentrine vs. placebo were classified as Transitional ...

The natriuretic peptides, specifically brain natriuretic peptide (BNP), are the most specific and applicable laboratory tests available to establish fluid overload associated with HF. 9 BNP is ...

Please provide your email address to receive an email when new articles are posted on . In more than 70% of patients with COPD, a positive expiratory pressure device improved exertional dyspnea. The ...

Among patients with chronic obstructive pulmonary disease (COPD) and severe chronic breathlessness, short-term daily treatment with low doses of extended-release morphine did not significantly reduce ...

Common causes of shortness of breath include physical deconditioning, obesity, anxiety, asthma, heart failure, heart attack, COPD, and pneumonia. However, feeling out of breath when walking short ...

Chronic obstructive pulmonary disease – which includes emphysema, chronic bronchitis and asthma – has become the fourth-leading cause of death and is one of the only major chronic diseases that has ...

Add Yahoo as a preferred source to see more of our stories on Google. "Oh, that's just from smoking." It's easy to dismiss a chronic cough as another problem with cigarettes. But what if it's a sign ...

Don't ignore the subtle changes in your stamina; persistent coughs and shortness of breath could be more than just signs of ...

The Pulmonary Embolism Dyspnea Italian Study (PEDIS), just published in the Journal of Thrombosis and Haemostasis, has demonstrated for the first time that the recent onset of severe respiratory ...

A yearly influenza vaccine reduces serious illness and death in COPD patients by nearly 50%. Pneumococcal polysaccharide vaccine is also recommended for COPD patients aged 65 years and older or those ...